In 2005 the most frequent genetic alteration involving ERG was found in prostate cancer (PCa), where the 5′-untrascribed region of the prostate-specific and androgen-responsive TMPRSS2 gene is fused to ERG in approximately 50% of PCa cases [11]. Here, TMPRSS2 is linked to prostate carcinoma.